Overview
The Department of Health, Disability and Ageing has registered the Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2026. This notice updates the official list of ingredients allowed in therapeutic goods, including complementary medicines, vitamins and supplements. The determination came into force on 13 October 2026.
What the Determination Covers
The document structure includes definitions, permissible ingredients, labelling warning requirements, and a schedule of specified ingredients. The source text does not detail which specific ingredients were added, removed or changed.
Who This Affects
This mainly affects businesses that manufacture, import, label or sell therapeutic goods and need to check their products use only permitted ingredients with correct warning statements.
Key Actions
- Businesses that manufacture, import or sell complementary medicines or therapeutic goods can check the full legislation text at https://www.legislation.gov.au/F2026L01382 to see which ingredients and labelling requirements have changed
- Product labels can be reviewed against the warning statement requirements in section 6A of the determination
- Businesses can confirm with their regulatory or compliance adviser whether any ingredients they use are affected by Schedule 1 of this determination
- An alert can be set up on the Federal Register of Legislation page for this title to track future amendments
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.